FET Fusion Oncoproteins Disrupt Physiologic DNA Repair and Create a Targetable Opportunity for ATR Inhibitor Therapy
Daniel E. Gracilla(National Sun Yat-sen University), Asmin Tulpule(Memorial Sloan Kettering Cancer Center)
Cited by 0
Related Papers
Overexpression of wild type or a Q311E mutant <i>MB21D2</i> promotes a pro‐oncogenic phenotype in HNSCC
|Molecular Oncology|2020|11
FET fusion oncoproteins disrupt physiologic DNA repair and create a targetable opportunity for ATR inhibitor therapy
|bioRxiv (Cold Spring Harbor Laboratory)|2023|5